There is a wealth of information for the Fellowship applicant both pre- and post-application and match regarding the Graduate Medical Education (GME) program here at Yale, as well as information about Yale New Haven Hospital, Yale University and New Haven.
Yale Medical Oncology-Hematology Program
The Yale Medical Oncology-Hematology Fellowship Program is a 36 month training program that adheres to the ACGME and ABIM guidelines for combined training in Medical Oncology and Hematology. The fellowship program provides comprehensive clinical training in the diagnosis and management of neoplastic and benign hematologic disorders and a robust research experience to prepare fellows for a career in academic medicine. Fellows have the opportunity to train in diverse health care systems and to care for a diverse patient population with respect to gender and socio-economic backgrounds.
The goal of the Yale Medical Oncology-Hematology Fellowship Program is to train the next generation of academic hematologists and oncologists devoted to laboratory-based or patient-oriented investigation. Thus, the program is designed and structured to provide not only comprehensive clinical training but also a rigorous research experience to prepare fellows for careers as clinician investigators or clinician scientists in academic medicine.
Fellows will complete 18 months of full time clinical training dedicated to the acquisition of the medical knowledge, clinical skills, and competence to practice Medical Oncology and Hematology. All fellows are required to engage in 18 months of research (clinical, translational, or basic science) under the mentorship of Yale Cancer Center faculty. In addition, fellows will complete 36 months of outpatient continuity clinics in six blocks of six months duration, ½ - 1 day per week, that include a general oncology clinic at the West Haven VA and five disease-specific clinics at Yale Medical Center.
In recognition of the increasing complexity of cancer therapy, particularly with respect to the interface between laboratory discovery and clinical care, the fellowship training has been organized to provide experience in the multidisciplinary care of patients, supplemented by an intensive program of didactic lectures, inter-disciplinary tumor boards, research seminars, and formal coursework. The outpatient clinics are structured according to specific diseases (e.g., breast cancer, lymphoma, lung cancer, benign hematologic disease, etc). Each disease-specific unit is supported by a weekly inter-disciplinary tumor board attended by specialized faculty members from other departments, where patients are discussed in depth with review of pathologic and radiological data. The disease-specific units facilitate the clinical and translation research programs at Yale and improve patient care by consolidating complex and inter-disciplinary management.
Clinical Training in Year One (12 mo) and Year Two (6 mo):
During the first year of training, fellows rotate through four clinical blocks as follows: (1) six months continuously in ambulatory clinics, where fellows care for a panel of patients over six months in disease-specific units; (2) 1.5 months on Yale-New Haven Hospital's Adult In-patient Oncology Unit and Oncology Consult Service, where the fellows participate in the acute care of patients with solid tumors, support and teach the team of residents on the unit, and see in-patient oncology consults on other services throughout Yale-New Haven Hospital; (3) three months at the VA Connecticut Health Care System of West Haven, where fellows actively participate in the Hematology and Oncology out-patient clinics and consult on the in-patient service at the West Haven Veterans Administration Hospital; (4) 1.5 months at the Hospital of St. Raphael's, where fellows participate in the out-patient clinic devoted to caring for indigent and under-insured patients, see in-patient hematology and oncology consults, and lead the care team on the dedicated in-patient oncology unit.
During the second year, fellows rotate through 4 clinical blocks at Yale-New Haven Hospital, focused on hematology: (1) 1.5 months on the Bone Marrow Transplantation unit; (2) two months on the Hematology Consult Service, where fellows provide consultative services in the discipline of hematology to patients on the general wards and intensive care units at Yale-New Haven Hospital; (3) 1.5 mo on the Adult Leukemia/Lymphoma Unit, where fellows participate in the acute care of patients with hematologic malignancies and complications of transplantation. (4) one month in Yale-New Haven Hospital's Transfusion and Laboratory Medicine Department, focused on blood banking, coagulation testing, flow cytometric analysis, and hematopathology.
Research Training in Year Two (6 mo) and Year Three (12 mo):
The second year (6 mo) and third year of training are devoted to research. All fellows are expected to engage in a hypothesis-driven research project in a clinical, translational, or basic science arena. During the research block, the fellow spends the majority of his/her time engaged in their research project, under the mentorship and supervision of a faculty advisor, while continuing a continuity outpatient clinic experience in disease-specific units at Yale.
A committee of at least three faculty members will be assigned to each fellow to monitor their progress and provide additional mentoring and career counseling during Years Two and Three of their training. The individual mentorship committee assists fellows in identifying a research mentor and project based on individual interests and career goals. The committee also provides guidance on grant applications and employment opportunities.
2nd and 3rd year fellows are expected to present their research at least annually at the Research in Progress conference. In addition, it is expected that each fellow’s research activities will lead to at least one abstract presentation at a national meeting (e.g., ASCO, ASH, AACR) and at least one peer-reviewed publication. Concurrent course work offered through the University is recommended to augment the fellow’s research goals, and, specifically, fellows are expected to enroll in one or more of the core courses offered through the Investigative Medicine Program (see below Research Opportunities and Programs). In addition, fellows who are pursuing a career in clinical investigation are expected to submit an application to the AACR/ASCO Workshop on Methods in Clinical Cancer Research (“Vail Workshop”) or the ASH Clinical Training Research Institute.
Research Opportunities and Programs:
There are diverse opportunities for clinical, translational, or basic research within the Sections of Medical Oncology and Hematology and throughout the Yale School of Medicine, including Yale Center for Molecular Discovery at West Campus. Importantly, fellows may pursue cancer-related or hematologic research in other departments or sections within the School of Medicine, and thus have access to a vast array of research opportunities in clinical, outcomes, translational, and basic arenas.
In addition, Yale Center for Clinical Investigation, funded by NIH’s Institutional Clinical and Translational Science Award (CTSA), provides a robust infrastructure to promote collaborative clinical and translational research of post-doctoral fellows and junior faculty. The YCCI provides an array of resources to support clinical and translational research efforts of post-graduate fellows, including biostatistics and study design, biomedical informatics, clinical research resources, translational core research facilities, et al. YCCI supports several initiatives specifically focused on the educating and training of clinical fellows and junior faculty in inter-disciplinary research approaches and technologies, including the YCCI Junior Faculty Scholars Program and the Investigative Medicine PhD Program (IMP). The IMP is a unique clinically-based or laboratory-based research training program for clinical fellows that will lead to a PhD in Investigative Medicine at the completion of fellowship training. Hematology-Oncology fellows who are interested in rigorous research experience, including a comprehensive didactic curriculum, are encouraged to apply to the IMP.
Didactic Sessions, Conferences, Tumor Boards:
The clinical and research training of the Medical Oncology-Hematology Fellowship is enhanced by several weekly lectures, conferences, seminars, and interdisciplinary tumor boards which include the following:
Medical Oncology-Hematology Core Curriculum Course *
Weekly lectures providing a comprehensive review of all aspects of medical oncology and hematology including oncologic emergencies, pharmacology, palliative care, biostatistics and clinical trial design, cancer epidemiology, cancer genetics, and in-depth reviews of each specific neoplastic and benign hematologic disease. The disease-specific reviews include the relevant basic biology, pathogenesis, epidemiology, staging, use of imaging, prognostic variables, and treatment. This course runs over 18 months.
Cancer Center Grand Rounds *
A weekly forum for Yale faculty and guest speakers to provide state-of-the-art updates on a broad array of cancer-related topics.
Journal Club *
Twice monthly (October - June) presentation at which important articles relevant to hematology-oncology are critically reviewed and presented by the fellows, with input and mentoring from appropriate faculty members.
Research in Progress meeting *
A weekly conference (September - May) where faculty and fellows present their research.
New Patient Conference *
A weekly conference presented in a “morning report” format, new patients seen by the first year fellows are presented for case-based discussion. Attending faculty members are active participants, contributing their expertise to the discussion. In addition, this conference is used as a forum to review complications of treatment and adverse outcomes in the format of a Morbidity and Mortality Conference, three-four times annually.
Disease-specific Case Conference *
A weekly conference in which new patients from one disease-specific unit are presented to an attending physician with expertise in that disease area for a detailed case-based discussion of staging, biology, treatment, with emphasis on evidence-based management and review of the use of specific therapeutic agents.
Hematology/Hematopathology Conference *
A weekly case-based conference in which benign and malignant hematology cases are discussed with the participation of the hematopathologists. An important aspect of this conference is review of peripheral blood smears, bone marrow aspirates and biopsies. Specialists from the Department of Laboratory Medicine, including the Blood Bank, are invited to participate to discuss specific cases.
Interdisciplinary meetings to present new patients, review pathology and radiographic studies, and discuss evidence-based management; tumor boards are held weekly for each multidisciplinary disease-specific unit.
Asterisk (*) indicates that attendance by fellows is required. Fellows are expected to attend at least 70% of mandatory conferences.
Program Leadership and Administration:
Dr. Roy Herbst and Dr. Madhav Dhodapkar are the Chiefs of the Section of Medical Oncology and the Section of Hematology, respectively. Dr. Jill Lacy is the Director of the Medical Oncology-Hematology Fellowship Training Program. Dr. Nikolai Podoltsev is the Associate Program Director for Hematology and Dr. Harriet Kluger is the Associate Program Director for Research. Dr. Michal Rose is the local on-site director of fellowship activities at the VA CT Healthcare System of West Haven, where she is also the Chief of the Section of Hematology-Oncology and Cancer Center Director. At St. Raphael’s Hospital in New Haven, Dr. Andrea Silber is the local on-site director of fellowship activities. The Fellowship Administrator and Coordinator is Savannah Woods.
The program accepts eight trainees per year for a minimum of three years of combined training in Hematology and Medical Oncology. All applications for the 2015 Training Program in Medical Oncology-Hematology will be electronically processed through the ERAS (Electronic Residency Application Service) website. Interviews are granted by invitation in September and October. Selection for the program is made through the NRMP (National Resident Matching Program). The Sections of Medical Oncology and Hematology actively support Yale University policies and programs for affirmative action. The Fellowship Program is fully committed to recruitment and development of minority group members and women.
Submission to the 2016 Hematology/Medical Oncology fellowship program through ERAS begins on July 15, 2015 with an application deadline for August 31, 2015. Please refer to the ERAS website for their opening date for filing application materials. If selected for interview, interviews will be held from mid-September to mid-October.
Required application materials for our program are as follows: Common Application Form (CAF), Statement of Personal Goals, minimum of three (3) letters of recommendation (at least one must be from either the Residency Program Director or Internal Medicine Department Chair), ECFMG certification (applicable to graduates of Foreign Medical schools), and a Color Photo. Additional items such as Medical School and USMLE Transcripts are optional.
Questions regarding the application process can be directed to Savannah Woods.